408 results on '"Hamuryudan V"'
Search Results
2. POS0727 DEVELOPMENT OF POSTERIOR UVEITIS IN BEHÇET’S SYNDROME PATIENTS WITH VITREOUS CELLS WITHOUT ANY OTHER POSTERIOR INVOLVEMENT
3. AB0730 TOCILIZUMAB TREATMENT IN SEVERE AND REFRACTORY BEHÇET’S SYNDROME: A CASE SERIES
4. AB0713 FREQUENCY OF TUBERCULOSIS AND ASSOCIATED RISK FACTORS IN PATIENTS WITH BEHÇET’S SYNDROME
5. A NEW SCREENING TOOL FOR PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS: TURPAS
6. Behçet’s Syndrome : The Cerrahpasa Experience
7. POS1255 SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET’S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER
8. POS0816 DRUG SURVIVAL OF INFLIXIMAB IN BEHÇET’S SYNDROME PATIENTS WITH DIFFERENT TYPES OF INVOLVEMENT
9. AB1308 MYCOPHENOLATE FOR THE TREATMENT OF EYE INVOLVEMENT IN PATIENTS WITH BEHÇET’S SYNDROME
10. POS0814 OUTCOME OF VASCULAR INVOLVEMENT OF BEHÇET’S SYNDROME TREATED WITH INFLIXIMAB: A RETROSPECTIVE COHORT STUDY
11. AB0601 FACTORS ASSOCIATED WITH THROMBOSIS IN BEHÇET SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
12. POS1363 THE VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF BEHÇET’S SYNDROME OVERALL DAMAGE INDEX IN A RETROSPECTIVE COHORT
13. AB0938 A new screening tool for Psoriatic Arthritis in Psoriasis Patients: TurPAS
14. AB0635 Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis
15. AB1305 A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHÇET’S SYNDROME
16. Behçet’s syndrome with emphasis on clinical genetics and mortality
17. INSTRUMENTS FOR SCREENING PSORIATIC ARTHRITIS AMONG PATIENTS WITH PSORIASIS: A SYSTEMATIC LITERATURE REVIEW
18. DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHCET SYNDROME
19. INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME
20. EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHCET SYNDROME
21. POS0820 INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHÇET SYNDROME
22. AB0579 INSTRUMENTS FOR SCREENING PSORIATIC ARTHRITIS AMONG PATIENTS WITH PSORIASIS: A SYSTEMATIC LITERATURE REVIEW
23. POS0819 EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHÇET SYNDROME
24. POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET SYNDROME
25. POS0814 DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHÇET SYNDROME
26. POS1187 WILLINGNESS TO GET THE COVID-19 VACCINE AMONG PATIENTS WITH RHEUMATIC DISEASES, HEALTH WORKERS AND GENERAL POPULATION
27. Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease
28. A survey of hospitalisation in behçets syndrome: APLAR-0084
29. Glomerulonephritis in Behçet’s Disease: Report of Seven Cases and Review of the Literature
30. Frequent oral ulceration during early disease may predict a severe disease course for men with Behçetʼs syndrome: 703924
31. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists
32. Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behçet's Syndrome
33. FRI0202 WHAT IS NOT NERVOUS SYSTEM INVOLVEMENT IN BEHÇET SYNDROME: A SURVEY OF PATIENTS WITH BEHÇET SYNDROME REFERRED TO NEUROLOGY
34. FRI0237 COMPARISON OF DIFFERENT PULMONARY HYPERTENSION SCREENING ALGORITHMS IN PATIENTS WITH SYSTEMIC SCLEROSIS
35. SAT0258 DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHÇET SYNDROME
36. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease
37. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
38. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis
39. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists
40. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study
41. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behçet's syndrome
42. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease
43. Effects of interferon-α treatment on serum IL-6, IL-8, TNF-α and soluble TNF-α receptors in Behçetʼs disease
44. Coronary atherosclerosis in Behçetʼs syndrome: a pilot study using electron-beam computed tomography
45. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjögren’s syndrome: a case–control study
46. Behçet’s Syndrome
47. Papulopustular skin lesions are seen more frequently in patients with Behçetʼs syndrome who have arthritis: a controlled and masked study
48. Intestinal permeability in Behçetʼs syndrome
49. Calciphylaxis: A condition mimicking necrotizing vasculitis
50. Genetic anticipation in Behcet's syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.